miRNA Tools Lead Development of Next-Generation Therapeutics and Diagnostics

miRNA Tools Lead Development of Next-Generation Therapeutics and Diagnostics

Although microRNAs (miRNAs) represent only a small fraction of the total RNA mass in a given sample - estimated at about 0.01% - the short RNA molecules (16-35 nucleotides) are widely viewed as a rich analytical resource for biomarkers and drug targets. miRNAs are believed to be involved in the regulation of more than 30% of protein-coding human genes through a complex regulatory network. Through broad gene regulation activity, miRNAs influence a range of cell processes and consequently play rol...


Affymetrix Acquisition Deepens and Complements Thermo Fisher’s Existing Product Groups in Clinical Molecular Testing, Translational Research, Flow Cytometry and Applied Testing

Affymetrix Acquisition Deepens and Complements Thermo Fisher’s Existing Product Groups in Clinical Molecular Testing, Translational Research, Flow Cytometry and Applied Testing

Kalorama Information offers additional analysis of the markets discussed below with an upcoming title on clinical and research microarrays as well as published reports including The Market for Prenatal, Newborn and Carrier Genetic Testing , The World Market for Cancer Diagnostics, 6 th Ed. , Proteomics Research Markets , The World Market for Flow Cytometry in IVD Applications , and The World Market for Veterinary Diagnostics.

Thermo Fisher Scientific’s reach in the global life sciences market ...


Catch Up on Prenatal and Neonatal Testing Technologies and Industry Moves with Kalorama’s Clinical OMICs Article

Catch Up on Prenatal and Neonatal Testing Technologies and Industry Moves with Kalorama’s Clinical OMICs Article

Kalorama Information provides comprehensive insights into the prenatal and neonatal testing markets and industry with The Market for Prenatal, Newborn and Carrier Genetic Testing. Read more regarding the market with Kalorama’s article in Clinical OMICs - Prenatal Testing Upgraded with Sequencing, Microarrays and Mass Spec.

The prenatal testing market has become, technologically speaking, quite diverse in less than 10 years. Industry stalwart PerkinElmer serves as an effective case study as it ...